PB1F2 is a proapoptotic protein encoded by an alternative reading frame in the influenza A virus. Its accumulation accelerates mitochondrial fragmentation by decreasing the mitochondrial membrane potential following translocation into the mitochondrial inner membrane space, but the mechanistic underpinnings remain unclear. Herein, the PB1F2 from HK97 was expressed and purified in soluble form. The interaction between PB1F2 and the mitochondrial membrane were investigated using three membrane mimics, liposomes, bicelles, and nanodiscs. We show that the interactions between PB1F2 and membrane mimics depend on lipid type and are time-and dose-dependent. The primary membrane target of PB1F2 is phosphatidylcholine, the lipid that forms the major component of mitochondrial inner membranes. PB1F2 disrupts the integrity of lipid membranes by forming micelle-like PB1F2-lipid assemblies.
PB1F2 is a proapoptotic protein encoded by an alternative reading frame in the influenza A virus. Its accumulation accelerates mitochondrial fragmentation by decreasing the mitochondrial membrane potential following translocation into the mitochondrial inner membrane space, but the mechanistic underpinnings remain unclear. Herein, the PB1F2 from HK97 was expressed and purified in soluble form. The interaction between PB1F2 and the mitochondrial membrane were investigated using three membrane mimics, liposomes, bicelles, and nanodiscs. We show that the interactions between PB1F2 and membrane mimics depend on lipid type and are time-and dose-dependent. The primary membrane target of PB1F2 is phosphatidylcholine, the lipid that forms the major component of mitochondrial inner membranes. PB1F2 disrupts the integrity of lipid membranes by forming micelle-like PB1F2-lipid assemblies.
Keywords: influenza A virus; membrane disruption; micelle-like lipid assembly; NMR; PB1F2 PB1F2 is an 87-90 amino acid membrane protein encoded by an alternate reading frame in the influenza A virus PB1 gene that was discovered in 2001 [1] . Although PB1F2 is not necessary for virus replication, it is believed to be an important determinant of virulence because it promotes host cell death, causes immunopathology, and increases proinflammatory responses [2] . Indirect immunofluorescence analysis of infected cells demonstrated that most PB1F2 localize to mitochondria, while small portion goes to the cytoplasm and nucleus [3] . The mitochondrial localization is notable because PB1F2 decreases the mitochondrial membrane potential [2] and induces apoptosis, particularly in human monocytic cells. It also sensitizes cells to proapoptotic stimuli such as tumor necrosis factor (TNF) [4] [5] [6] . Some studies reported that PB1F2 interacts with other proteins including modulator of apoptosis 1 (MOAP-1), mitochondrial antiviral signaling protein (MAVS) [7] , and inhibitor of nuclear factor kappa-B kinase (IKKb) [8] , most of which are related to mitochondria. Mitochondrial targeting of PB1F2 is mediated largely by the predicted helices in the Cterminal region of the protein, and peptides corresponding to this region are believed to oligomerize and form nonselective pores that permeablize planar lipid membranes [9] .
Taken together, these findings support the idea that PB1F2 activates the apoptotic pathway during the mitochondrial regulation step. Modulation of the mitochondrial membrane potential (MMP), cytochrome c release, and bcl-2 antagonism of apoptosis are established indicators of interaction with this important apoptotic regulator pathway. Unfortunately, the molecular mechanisms underlying these intracellular physiological changes and their relationships to one another and to the apoptotic pathway remain to be defined.
It is still unclear how PB1F2 causes the mitochondrial membrane permeabilization. PB1F2 has been reported to promote the mitochondrial permeabilization by interacting with adenine nucleotide translocator 3 (ANT3) and voltage-dependent anion channel 1 (VDAC1), both of which are key components of the mitochondrial permeability transition pore complex, and thereby enhancing complex formation [10] . It is also reported that PB1F2 may directly permeabilize mitochondria by forming nonselective pores [11] , thereby lowering the MMP and releasing cytochrome c. A recent study [12] showed that PB1F2 is completely translocated into the mitochondrial inner membrane space via translocase of the mitochondria outer membrane 40 (Tom40), and its accumulation accelerates mitochondrial fragmentation by lowering Dwm. By contrast, PB1F2 variants lacking the C-terminal region, which is frequently found in low pathogenic subtypes, do not affect mitochondrial function. Furthermore, PB1F2 is believed to be constitutively localized to the mitochondrial inner membrane space (IMS), tightly associated with the mitochondrial inner membrane (MIM), where it assembles into a highly ordered oligomer. Together, these findings indicate that cellular apoptosis induced by PB1F2 may be due to the interaction between PB1F2 and the MIM.
The loss of transmembrane potential by PB1F2 has been studied in vivo and in vitro [13] . The ability of PB1F2 to associate with mitochondrial membranes is of great importance, particularly the potential to associate with MIM lipids phosphatidylcholine (PC), phosphatidylethanolamine (PE), and cardiolipin. As a good in vitro membrane study system, liposomes have been applied extensively to assess the membrane damage of PBF2. Using electrophysiological techniques, Chanturiya et al. found that synthetic PB1F2 peptides at nanomolar concentrations are able to induce a transmembrane conductance with large unilamellar vesicles (LUV) [9] . Moreover, PB1F2 has been reported to form protein channel pores with no appreciable ion selectivity for which the C terminus is necessary [11] . PB1F2 was reported to be monomeric with random coiled structure at pH5 [14] [15] [16] . PB1F2 protein can also adopt b-sheet conformation in the membrane-mimicking detergent or in the presence of liposomes. Although the amorphous PB1F2 aggregates at pH7.0 show no cytotoxicity, preassembled amyloid oligomers or fragmented nanoscaled fibrils were highly cytotoxic [15] .
So far, there is very little study on the lipid selectivity of PB1F2, especially how PB1F2 disrupts the mitochondrial inner membrane. In this study, the PB1F2 from HK97 was expressed and purified in soluble form. Membrane systems including bicelles, nanodiscs, and liposomes, were utilized to mimic the mitochondrial inner membrane and control membrane systems with various major lipid components. To study the membrane disruption mechanism, various biophysical approaches were applied to characterize the interaction between PB1F2 and mitochondrial inner membrane mimics.
Materials and methods
Bacterial strains, plasmids, media, and chemicals Escherichia coli strain BL21 (DE3) was used as the host for protein expression. Plasmid pET28a which carries the T7 promoter, a hex histidine tag coding sequence, and kanamycin resistance gene was used as an expression vector for MSP. All the lipids used, including NBD-
, cardiolipin, and cholesterol, were purchased from Avanti Polar Lipids (Alabaster, AL, USA). Restriction enzymes and DNA-modifying enzymes were purchased from Takara (Dalian, LN). Isopropyl-b-D-thiogalactopyranoside (IPTG) and all the other chemicals were from Sangon Biotech (Shanghai, China).
Constructions and protein expression
Genes coding for PB1F2 A/HK/156/1997 (H5N1) was artificially synthesized (Genescript, Nanjing, China) in pUC57 and amplified with gene-specific primers. PB1F2 genes were cloned in the E. coli expression vector pET-22 (Novagen, Darmstadt, Germany) after sumo gene between the Nde I and Xho I restriction sites. The SUMO construct is made by our lab according to the method described by Wang [17] .The vector (pET22-SUMO-PB1F2) was used to express N-terminal 6xHis-sumo fusion proteins without linker between SUMO and PB1F2. The sequence of each cloned gene was confirmed by nucleotide sequencing. Competent BL-21 (DE3) cells (Stratagene, Santa Clara, CA, USA) transformed with pET22-SUMO-PB1F2 plasmids were cultured to an OD600 of 0.8 in LB medium. To express PB1-F2, the transformed cells were incubated for 4 h at 25°C in 0.5 mM IPTG with agitation.
Proteins purification
Following incubation in IPTG, the transformed cells were pelleted by centrifugation during 10 min at 8000 g. All the recombinant sumo-PB1F2 proteins accumulated in soluble cytoplasm. After cell lysis by sonication in Tris-HCl 20 mM pH 7.5, NaCl 50 mM, the crude lysate was centrifuged during 20 min at 14 000 g at 4°C. The supernatant, containing the recombinant SUMO-PB1F2 proteins, was collected and loaded on a Ni 2+ affinity column (the sequence of SUMO-PB1F2 is shown in supplementary materials). Column fractions were analyzed by SDS/PAGE and coomassie blue staining. Fractions containing purified recombinant protein were pooled and dialyzed at 4°C overnight to remove imidazole. Home-made SUMO enzyme was added to digest recombinant sumo-PB1F2. After loaded on another Ni 2+ affinity column, PB1F2 proteins was purified by a Superdex75 10/60 (GE Healthcare, Pittsburgh, PA, USA).
Preparation of nanodiscs
The general procedure for self-assembly of nanodiscs is the same as that described previously [18] . In brief, the solution of purified DMSP (a deletion mutation of MSP1D1) at 0.15-0.3 mM concentration was combined with cholate-solubilized lipid to yield an optimal molar ratio, previously estimated from pre-experiments. After incubation at optimal temperature (often at phase transition temperature), the self-assembly process is initiated by adding appropriate amount of bio-beads. At last, nanodiscs were purified by Gel filtration on a Superdex 200 column (GE Healthcare).
Preparation of liposome
Liposomes composed of PC applied to mimic the mitochondrial inner membrane were prepared as described [19] . Briefly, lipids dissolved in CHCl 3 were dried under a stream of dry nitrogen gas and evaporated under high vacuum to dryness in a round-bottom flask. After resuspending the lipids in buffer, lipids were freezed and thawed by liquid nitrogen and 37°C water bath for five times. To obtain large unilamellar vesicles (LUVs), the lipid vesicles were extruded 23 times through polycarbonate filters (Nuclepore, Whatman) in a mini-extruder (Avanti Polar Lipids Inc., Alabaster, AL, USA) fitted with two 1-mL Hamilton gastight syringes (Hamilton, Reno, NV, USA). For the fluorescent assay of liposome, 1% (w/w) lipids NBD-PE was added.
Nuclear magnetic resonance spectroscopy
The NMR samples were prepared in 90% 20 mM phosphate buffer or Tris-HCl buffer of pH 7.2 containing 10% D 2 O. NMR spectra used in this study were collected using either a Bruker 600 MHz or a Bruker 850 MHz NMR spectrometer (Germany) equipped with pulse field gradients at 298K. All spectrometers were equipped with cryogenically cooled probes. 2D 1 H/ 15 N HSQC spectra were acquired on samples of uniformly 15 N-labeled PB1F2 in the absence or presence of phospholipid. All spectra were processed and analyzed by using the spectral processing and analysis systems NMRPipe and Sparky. Disruption of the mimic membrane by PB1F2 was examined by recording a series of 1D 31 P NMR spectra of phospholipids in nanodiscs (or bicelle and liposome) at 298 K. A series of 1D 31 P NMR spectra for both the free PB1F2
as well as the PB1F2 and nanodiscs mixture at a molar ratio of PB1F2/MSP in Nanodisc=1:1, were recorded on a Bruker 850 MHz spectrometer equipped with 31 P directdetection channel.
Calcein leakage assay
Dye leakage experiments were conducted by using calceinfilled LUVs at a final concentration of 200 lM. Dye-filled LUVs were prepared by hydrating the dry lipid film with the buffer solution containing calcein according to the procedure of liposome described above. The nonencapsulated calcein was removed by desalting on a HiTrap TM Deaslting column (GE Healthcare) equilibrated with 20 mM TrisNaCl buffer, pH 7.4. The first colored band containing the separated dye-containing vesicles was collected.
Samples were prepared by adding PB1F2 stock solution (200 lM) to 200 lL of a 200 lM LUV solution. Membrane disruption was quantified by detecting the increase in fluorescence emission intensity of calcein in a fluorimeter (SperctraMax i3x, Austria) using excitation at 490 nm and emission at 520 nm with a slit of 1 nm. After stabilization of calcein fluorescence, peptide in increasing concentrations was added and fluorescence enhancement was measured after 30 min of each addition. A quantity of 0.1% Triton X100 was used to obtain maximum fluorescence intensity. Percent leakage was calculated using:
where F is the fluorescence intensity after addition of peptide, F 0 is the basal fluorescence intensity, and F 100 is the maximum fluorescence intensity after addition of Triton X100. All measures were taken in triplicate at 25°C without stirring of the sample.
Results
Expression and purification of PB1F2 PB1F2, a major virulence factor of influenza A, is encoded by an alternative reading frame in the PB1-encoding RNA segment 2. PB1F2 from HK97 composes 90 amino acids (Fig. 1) , and can be expressed and purified in a soluble form. Fig. S1 shows the sequence alignment of the three most frequently studied PB1F2 variants derived from influenza A virus strains A/Puerto Rico/8/34 (H1N1) [20, 21] , A/ Wilson-Smith/1933 (H1N1) [14] [15] [16] , and HK97 (Fig. S1) .
A SUMO fusion PB1F2 recombinant was constructed and was overexpressed in E. coli BL21 cells. The recombinant was purified by Ni 2+ affinity chromatography. After enzyme digestion to cleave the SUMO fusion, PB1F2 was purified by collecting the flow-through fraction using Ni 2+ affinity chromatography. PB1F2 was further separated and collected with gel filtration chromatography (Fig. 1A) . The purified PB1F2 protein appeared as a single band with a molecular weight of~10 kDa on the tricine polyacrylamide gel (Fig. 1B) . The protein in gel was further identified by LC-mass to confirm the accuracy (Fig. S2) . The production yield of pure PB1F2 after gel filtration is about 0.5 mg per liter LB medium. To our knowledge, this is the first report of a recombinant PB1F2 soluble expression and purification with no need of denaturing and refolding treatment.
Membrane permeabilization of HK97 PB1F2 is lipid composition-dependent
To characterize the membrane permeability, PB1F2 was incubated with liposomes containing calcein, a fluorescent probe. The amount of calcein leakage upon PB1F2 addition was measured to quantify the relative alteration in membrane integrity. Liposomes of varying lipid composition were prepared, including negatively charged PS liposomes, neutral PC liposomes, mixed PC/PS liposomes at a molar ratio of 4 : 1, mixed PC/PS/CL/PE/PI liposome, mixed PC/ CL liposomes at a molar ratio of 10 : 1, and mixed PC/PS/CL/PE/PI liposome a lipid ratio (38%, 4%, 16%, 25%, and 16%) that mimics the mitochondrial inner membrane. As demonstrated in Fig. 2, PB1F2 destabilizes PC lipid liposomes, and the addition of 5 lM PB1F2 causes a complete calcein leakage. Nevertheless, no calcein leakage was observed when PB1F2 was added to liposomes composed entirely of negatively charged PS liposomes. The addition of PS (about 20%) reduces the calcein leakage down to 20%. For PC/CL liposomes, the addition of PB1F2 causes a complete calcein leakage like the case of pure PC lipid. For PC/PS/CL/PE/PI liposomes that mimic the mitochondrial inner membrane, the addition of PB1F2 causes an 83% calcein leakage. For liposomes composed of PC and cholesterol (the proportions of cholesterol is 40%), which mimics the mammalian cell membrane, only a negligible amount of leakage at the same concentration of peptide was observed. These results indicate that PB1F2 is lipid selective, and the primary membrane target of PB1F2 is PC lipid. To further identify which domain of PB1F2 is responsible for its membrane permeability, the calcein leakage upon PB1F2 addition were also characterized for peptide corresponding to the Nterminal 56 amino acids of PB1F2 (N56) and that of the C-terminal 34 amino acids of PB1F2 (C34). As shown in Fig. 2C , N56 displays little disruption to all six liposomes. However, the disruption ability of C34-PB1F2 is quite similar to the full length, especially for pure PC liposome and liposome mimicking mitochondrial inner membrane.
HK97 PB1F2 disrupts PC-containing liposomes into micelle-like assembly
Next, we focused on PC-containing liposomes to investigate the membrane permeabilization mechanism of HK97 PB1F2 using 31 P NMR spectroscopy. A typical powder pattern was observed for 31 P PC liposomes, but following the addition of PB1F2, a sharp peak around 0 ppm appeared, indicating the appearance of a lipid assembly with a smaller size and a faster tumbling rate. As time proceeded, more and more of this membrane component emerges (Fig. 3A) . As a control, in the absence of PB1F2, the 31 P spectrum of PC liposome shows no visible change after 66 h (Fig. S3) . Transmission electron microscopy [22] images demonstrated that the integrity of PC liposomes was diminished by PB1F2, and large liposomes broke into smaller particles (Fig. 3B,C) . This is different from PS liposomes which maintain their membrane integrity and show no disruption in the presence of PB1F2 (Fig. S4) . The breakdown of PC liposomes into micelle-like lipid assemblies by HK97 PB1F2 provides a reasonable explanation for the calcein leakage shown in Fig. 2B .
To quantify the amount of small lipid assemblies formed by PB1F2 disruption, we mixed fluorescent lipids NBD-PE into PC liposomes. Upon PB1F2 disruption, smaller sized lipid assemblies could be separated from liposomes by centrifugation at 70 000 g, and the NBD-PE fluorescence signal from the supernatant gives a good measurement of lipid micelle assembly. The results showed that a longer incubation time and a higher concentration of PB1F2 generated a larger proportion of lipid micelles (Fig. 3D,E) .
Membrane mimic systems other than liposomes were also applied to verify the lipid dependency of the PB1F2 disruption effect using PC/CHAPS and PS/CHAPS bicelles (Q=0.5). CHAPS detergent was used instead of DHPC to eliminate the signal complexity from DHPC in the 31 P NMR spectra. The results reveal that membrane disruption in the bicelle system by PB1F2 is also highly sensitive to lipid composition. As shown in the 31 P NMR spectra of PC/CHAPS bicelles (Fig. S5A) , a new lipid peak appears at 1.8 ppm after the addition of PB1F2, indicating the interaction between PB1F2 and PC/CHAPS bicelles. For bicelles composed of PS/ CHAPS, The PS signal at -0.6 ppm remains unchanged after adding PB1F2, indicating PB1F2 is not capable of disrupting PS/CHAPS bicelles (Fig. S5B) . This is consistent with above liposome data.
NMR characterization of micelle-like lipid assemblies
To further characterize the membrane disruption induced by HK97 PB1F2, particularly the micelle-like lipid assemblies, we utilized lipid nanodiscs, which have been proven to be a suitable tool for studying protein-lipid interactions by high-resolution NMR [23, 24] . Nanodiscs with varying lipid composition were assembled as previously described [18] , and the nanodisc fractions at 13 mL on a Superdex-200 gel filtration column were collected for further experiments. Figure 4A shows the 31 P spectra of PC nanodiscs after PB1F2 disruption. The chemical shift of the phosphoryl group of nanodisc PC is at À1.0 ppm, and a new peak at 1.7 ppm appears after 2 h incubation with PB1F2. The intensity of 1.7 ppm signal increases over time; meanwhile, the PC 31 P peak of the nanodiscs decreases in intensity. Such a time-dependent disruption in the PC nanodisc system was also observed for liposome and bicelle systems. Again, as a control, the 31 P spectrum of PC nanodiscs did not show obvious changes after 20 h incubation without PB1F2 at the same temperature (Fig. S6) . We verified the lipid dependency and selectivity for zwitterionic lipids in nanodiscs systems. Same as that observed in liposomes and bicelles, PB1F2 disrupts PC nanodiscs (Fig. S7A ), but not PS nanodiscs (Fig. S7B) , confirming the suitability of the nanodisc system for further NMR characterization.
Size exclusion chromatography was performed to separate the PB1F2-disrupted micelle fraction from the undisrupted nanodiscs. As shown in Fig. 4B , nanodisc elutes at an elution volume of 13 mL on a Superdex-200 column (blue profile). For PC nanodiscs incubated with PB1F2 for 20 h, the nanodisc fraction decreases and a low-molecular-weight fraction appears at an elution volume of 19 mL (red profile). The ratio of the low-molecular-weight fraction to undisrupted nanodiscs was~6 : 1, which is roughly the same ratio as that determined from the 31 P NMR spectrum acquired before size exclusion chromatography using the same sample (blue-lined spectrum in Fig. 4D ). The elution volume fraction of 19 mL, which is termed as 'small fragmented membranes', was isolated and concentrated for further characterization.
The 31 P NMR spectrum of the separated 19 mL fraction exhibits an identical sharp 31 P signal at 0.9 ppm (red-lined spectrum in Fig. 4D ). The presence of PB1F2 protein in these small fragmented membranes was verified by LC-MS with a sample after acetone precipitation treatment (Fig. S8) . We also analyzed the 19 mL fraction by solution NMR using 15 N-1 H HSQC experiments (Fig. 4C) . The tryptophan sidechain signals around 10 ppm can be easily recognized. Four of the five tryptophans in PB1F2 sequence, locate in the C terminus, which is predicted to be the membrane associate region. The proton chemical shift changes in tryptophan sidechain region indicate that conformational changes happen when free PB1F2 becomes lipid bound in the small fragmented membranes.
Discussion
PB1F2 was first identified as a membrane protein localized to mitochondria that induces cell death.
Researchers have synthesized PB1F2 (PR8) and its fragments by solid-phase peptide synthesis (SPS) methods, and investigated the biological functions of the peptides [16, 17] . Chevalier et al. [15] first reported the expression of PB1F2 in E. coli BL21 and subsequent purification by unfolding and refolding of insoluble inclusion bodies. The refolded PB1F2 protein adopts a b-sheet conformation and forms amyloid fibers in membrane environments containing SDS. In the present work, we developed a new PB1F2 construct to obtain soluble protein without unfolding and refolding treatments. The resultant PB1F2 protein displayed characteristics that were distinct from the refolded protein described previously. The expression of soluble protein PB1F2 (WSN) without unfolding and refolding using our construct is also successful. PB1F2 (WSN) is expressed as inclusion bodies using SUMO as a fusion protein (data not shown). Differences in sequence and the experimental approaches used to acquire recombinant protein may be responsible for the apparent discrepancy in secondary structure between PB1F2 from HK97 and similar proteins reported previously.
Model membrane mimics are advantageous because they simplify a complex system and allow hypotheses to be tested under controlled conditions. Although the mimic membranes used herein represent a simplification of the complex nature of mitochondrial membranes, our findings may prove useful for elucidating the mechanism underlying the toxicity of PB1F2 to mitochondria. We got similar results of membrane disruption by PB1F2 using three different kinds of membrane mimics. Nanodiscs seem more convenient for the further separation of micelle-like lipid assemblies.
EGFP fusions confirmed the MIM localization of PB1F2 [13] , but exactly how PB1F2 decreases the membrane potential remains unclear. Although it is widely accepted that disruption of the integrity of the mitochondrial membrane by PB1F2 is related to changes in the MMP, the mechanism underlying this process is still not completely understood. Probes that are sensitive to the MMP, such as mito-tracker, have been used to test the influence of PB1F2 on the MMP in vivo [10] . Similarly, in vitro permeabilization tests can be carried out by monitoring liposome leakage, and this approach also confirmed the ability of PB1F2 to affect the MMP [14] [15] [16] . The mitochondrial targeting of PB1F2 is mediated largely by the predicted helices in the C-terminal region of the protein [13] . Our calcein leakage data show that the disruption ability of C34 is quite similar to the full length, whereas the N56 construct missing the C-terminal domain causes little disruption to liposomes with various lipid compositions. This result demonstrates that the disruption of the membrane is driven by the Cterminal region, and explains the low pathogenicity of H1N1 viruses with PB1F2 protein lacking the C-terminal domain.
It is generally believed that electrostatic interaction between a highly charged cationic peptide and anionic lipids play important role in PB1F2 membrane binding. But based on the results from this study, such electrostatic interaction does not seem to contribute much to membrane disruption. The PB1F2 protein we expressed in E. coli permeabilized PC liposomes, but not PS liposomes, since there was no disruption to nanodiscs or bicelles containing pure PS lipid. The interaction between the PB1F2 membrane and the POPG membrane is also studied and there is no obvious disruption the same as PS (Data not shown). By contrast, fulllength PB1F2 and the C terminus of PB1F2 interacted readily with membranes composed of the zwitterionic PE and PC, which are two of the most abundant lipids in the MIM [25] . The inclusion of mitochondria related phospholipid cardiolipin in PC nanodiscs shows similar disruption to that of PC nanodiscs (Fig. S9) . PB1F2 induces disruption of MIM mimics using PC/CL nanodiscs, resulting in the formation of micelle-like lipid assemblies. The cytomembrane which also contains lots of PC is not permeable to PB1F2, which we believe is due to the protection effect from cholesterol, as suggested from the liposome leakage experiment on PC/cholesterol. Herein, we postulate that PB1F2 is translocated to mitochondria by TOM40 in a nondestructive process, and disruption begins following binding to the MIM. Disruption of zwitterionic lipid membranes was more efficient than that of anionic ones, suggesting that electrostatic interactions may trap PB1F2 in several suboptimal interconverting conformations on the membrane surface, thereby hindering its ability to induce membrane disruption.
In the present work, recombinant PB1F2 caused similar fragmentation in three different model membrane mimics. A new membrane fraction was obtained when using nanodiscs and the protein-lipid micelles consisted of a mixture of PB1F2 and lipids. In the 1D 1 H- 15 N HSQC NMR spectrum, the amide proton chemical shifts from the PB1F2-lipid micelles sample disperses in a narrow range of 1 ppm indicating that the lipid bounded PB1F2 from HK97 is unstructured or adopts an a-helical conformation. This seems to be different from previous reports that PB1F2 form oligomers and mature amyloid fibers can be found during the interaction process between PB1F2 and liposome [14] . The conformation differences observed are likely due to the fact that they are at different interaction stages. Different from previous experiments where the strand conformation were observed in a short period of time, the membrane disruption takes longer time and ends in the stable formation of micelle-like lipidic PB1F2 (protein-lipid micelles). Several lines of evidence from AMP peptide studies also suggest that membrane disruption is a multistep process with distinct binding, oligomerization, membrane insertion, and pore formation steps [19, 26] . For example, MSI-78 was reported to form small membrane fragments composed of a mixture of anionic and zwitterionic lipids [27] . Similar to the observation in this study, an isotropic peak near 0 ppm, an indication of small and isotropic phosphoryl-lipid component, appears in the 31 P NMR spectrum. Additionally, the oligomers of asynuclein are able to propagate membrane damage in a fractal-like pattern [28] . The similarity between HK97 PB1F2 and AMPs, suggests that the formation of micelle-like protein-lipid assemblies is a general membrane disruption mechanism.
In conclusion, we studied the interactions between PB1F2 from HK97 influenza virus and various membrane mimics. The disruption ability of PB1F2 was found to be lipid-selective and time-dependent. The primary membrane target of PB1F2 protein is phosphatidylcholine lipid that forms the major component of mitochondrial inner membranes. We postulate that the formation of micelle-like PB1F2-lipid assemblies could play an essential role in mitochondrial membrane disruption.
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